2017 Buyer’s Guide

This buyer’s guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

AMA Issues Category III CPT Codes for HeartFlow's FFRCT Technology

 

July 5, 2017—HeartFlow, Inc. announced that the American Medical Association has issued a set of new category III Current Procedural Terminology (CPT) codes for fractional flow reserve computed tomography (FFRCT) technology, which helps clinicians diagnose and treat patients with suspected coronary artery disease (CAD). The CPT code application was submitted collectively by the American College of Cardiology, the Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Angiography and Interventions. The new CPT codes will become effective on January 1, 2018.

The CPT codes are:

  • 0501T—Noninvasive estimated coronary FFR derived from coronary CTA data using computation fluid dynamics physiologic simulation software analysis of functional data to assess the severity of CAD; data preparation and transmission, analysis of fluid dynamics and simulated maximal coronary hyperemia, generation of estimated FFR model, with anatomical data review in comparison with estimated FFR model to reconcile discordant data, interpretation and report
  • 0502T—Data preparation and transmission
  • 0503T—Analysis of fluid dynamics and simulated maximal coronary hyperemia, and generation of estimated FFR model
  • 0504T—Anatomical data review in comparison with estimated FFR model to reconcile discordant data, interpretation, and report

According to the company, the HeartFlow FFRCT is the first-of-its-kind and the only noninvasive technology to provide insight into both the extent of CAD and the impact of the disease on blood flow to the heart. HeartFlow FFRCT is designed to enable clinicians to select a definitive, personalized treatment plan for each patient and reduce the need for additional invasive testing.

With the new CPT codes, hospitals and clinics using HeartFlow FFRCT will now be able to generate claims with both Medicare and commercial payers when FFRCT is ordered for patients with suspected CAD, advised HeartFlow.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.